Analyzing the Benefits and Costs of the Safe Step Act on Patients, Physicians, and Insurers
{{output}}
Pharmaceutical expenditures in the United States, particularly in dermatology, have grown rapidly, driven by expensive topical and biologic treatments. Insurers are employing cost-containing strategies such as step therapy, which mandates the use of lower-cost... ...
